文献速递生殖医学

早期妊娠头三个月重复血清吻素测定对妊娠结局的预后价值:一项初步研究

Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study.
PubMed 文献 · Reprod Biomed Online · 2018-12-07

该病例对照研究在学术医疗中心纳入经体外受精和卵胞浆内单精子注射受孕的无合并症女性,在妊娠检测时及4天后采集血清,比较吻素与β-人绒毛膜促性腺激素对生化妊娠丢失、早期流产和活产妊娠的预测价值。结果发现生化妊娠丢失者吻素水平低于其他两组,但单次吻素测定无法区分早期流产与持续妊娠,连续测定也不优于β-人绒毛膜促性腺激素。

要点

  • 生化妊娠丢失组吻素水平低于早期流产组和活产妊娠组。
  • 妊娠检测时早期流产与活产妊娠两组吻素水平无显著差异。
  • 连续吻素测定判断妊娠结局的效果不如β-人绒毛膜促性腺激素。

核心结论

  • 单次血清吻素测定在妊娠与非妊娠女性间显著改变,但未能区分早期妊娠中的流产与持续妊娠。
  • 单次或连续吻素测定对早期流产的诊断性能均不高于β-人绒毛膜促性腺激素。
  • 吻素水平升高与流产风险降低相关。

研究设计与样本

  • 学术医疗中心开展的病例对照研究,纳入经体外受精和卵胞浆内单精子注射受孕且无混杂合并症的患者。
  • 在妊娠检测时采集母体血清,妊娠检测阳性者于4天后再次采集血清。
  • 根据随访结果纳入生化妊娠丢失24例、早期流产21例和活产妊娠28例。

主要发现

  • 生化妊娠丢失组吻素水平低于早期流产组和活产妊娠组。
  • 妊娠检测时,早期流产组与活产妊娠组吻素水平无显著差异。
  • 连续血清吻素测定判断妊娠结局的效果不如β-人绒毛膜促性腺激素。
  • 吻素水平升高与流产风险降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the diagnostic value of maternal kisspeptin in patients with asymptomatic first-trimester pregnancies, and what is the prognostic significance of kisspeptin versus beta-HCG in early pregnancies. DESIGN: Case-control study in academic medical centres. Patients with no confounding co-morbidities who conceived by IVF and intracytoplasmic sperm injection were analysed. Maternal serum samples were assessed at the time of pregnancy testing. Women who achieved a positive pregnancy test were asked to take serum samples 4 days later. According to the follow-up results, patients who experienced biochemical pregnancy loss (n = 24) and early miscarriage (n = 21), and women who achieved a viable pregnancy (n = 28), were included in this study. Serum samples were collected to detect kisspeptin and beta-HCG, respectively. RESULTS: Single serum determinations of kisspeptin and beta-HCG were correlated with the different pregnancy outcomes. Women who experienced biochemical pregnancy loss showed lower kisspeptin levels than those in groups B and C. No significant difference, however, was observed at the time of pregnancy testing in women who had experienced early miscarriage and those who had achieved viable pregnancy. Sequential measurements of serum kisspeptin are not as effective as beta-HCG in determining pregnancy outcome. Increased kisspeptin level was associated with reduced miscarriage risk. CONCLUSION: Single serum measurement of kisspeptin is significantly altered in pregnant and non-pregnant women. However, it failed to discriminate between miscarriage and ongoing pregnancies in first-trimester pregnancy. Neither single nor sequential kisspeptin have higher diagnostic performance for miscarriage than beta-HCG in early stage.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yu H, Liu J, Guo H, et al. Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reprod Biomed Online. 2018. PMID: 30718048. doi:10.1016/j.rbmo.2018.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。